Literature DB >> 17976912

Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation.

Ismael Santa-María1, Felix Hernández, Francisco J Moreno, Jesús Avila.   

Abstract

Taurine is an abundant aminoacid present in brain. Its concentration is decreased in the brain of Alzheimer's disease (AD) patients. The chemical structure of taurine is similar to 3-amino-1-propanesulfonic acid, a known compound which interferes with beta-amyloid peptide aggregation. Here, we have tested if taurine show similar properties. Taurine slightly decreases beta-amyloid peptide aggregation at a milimolar concentration. At that concentration, taurine favours the assembly of tau protein into fibrillars polymers. Thus, it is proposed that the negative charge present in taurine may be involved in the binding to tau protein, facilitating its assembly. In addition, the possible role of taurine in Alzheimer disease is commented.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976912     DOI: 10.1016/j.neulet.2007.09.068

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Melatonin Prevents the Harmful Effects of Obesity on the Brain, Including at the Behavioral Level.

Authors:  Adrian Rubio-González; Juan Carlos Bermejo-Millo; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; José Antonio Boga; Ignacio Vega-Naredo; Beatriz Caballero; Juan José Solano; Ana Coto-Montes
Journal:  Mol Neurobiol       Date:  2017-10-30       Impact factor: 5.590

2.  Direct reaction of taurine with malondialdehyde: evidence for taurine as a scavenger of reactive carbonyl species.

Authors:  Guolin Li; Ting Tang; Mijun Peng; Hong He; Dazhong Yin
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

Review 3.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

4.  Effect of Taurine on the antimicrobial efficiency of Gentamicin.

Authors:  Mina Islambulchilar; Mohammad Reza Sattari; Mohammad Sardashti; Farzaneh Lotfipour
Journal:  Adv Pharm Bull       Date:  2011-12-15

5.  Investigation Covering the Effect of Boron plus Taurine Application on Protein Carbonyl and Advanced Oxidation Protein Products Levels in Experimental Alzheimer Model.

Authors:  Cigdem Yildirim; Atiye Seda Yar Saglam; Sevin Guney; Burak Turan; Meral Ebegil; Sule Coskun Cevher; Barbaros Balabanli
Journal:  Biol Trace Elem Res       Date:  2022-05-27       Impact factor: 3.738

6.  Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways.

Authors:  Kaidong Wang; Baofu Zhang; Tian Tian; Bingyang Zhang; Ge Shi; Chunhui Zhang; Guoliang Li; Min Huang
Journal:  Amino Acids       Date:  2021-11-27       Impact factor: 3.520

7.  Therapeutic effect of taurine against aluminum-induced impairment on learning, memory and brain neurotransmitters in rats.

Authors:  Lu Wenting; Liu Ping; Jiao Haitao; Qiao Meng; Ren Xiaofei
Journal:  Neurol Sci       Date:  2014-04-27       Impact factor: 3.307

8.  Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease.

Authors:  Linn Hege Nilsen; Menno P Witter; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-05       Impact factor: 6.200

Review 9.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

10.  EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques.

Authors:  Hye Yun Kim; Hyunjin Vincent Kim; Seonmi Jo; C Justin Lee; Seon Young Choi; Dong Jin Kim; YoungSoo Kim
Journal:  Nat Commun       Date:  2015-12-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.